Rafferty Asset Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $34M | Sell |
156,378
-59,740
| -28% | -$13.3M | 0.14% | 85 |
|
|
2025
Q4 | $49.4M | Sell |
216,118
-18,012
| -8% | -$4.1M | 0.17% | 80 |
|
|
2025
Q3 | $54.2M | Sell |
234,130
-2,784
| -1% | -$567K | 0.18% | 77 |
|
|
2025
Q2 | $44M | Buy |
236,914
+22,485
| +10% | +$4.18M | 0.15% | 82 |
|
|
2025
Q1 | $44.9M | Sell |
214,429
-62,957
| -23% | -$12.2M | 0.19% | 69 |
|
|
2024
Q4 | $49.3M | Buy |
277,386
+11,042
| +4% | +$2.03M | 0.17% | 75 |
|
|
2024
Q3 | $52.6M | Sell |
266,344
-35,647
| -12% | -$6.65M | 0.18% | 68 |
|
|
2024
Q2 | $51.8M | Buy |
301,991
+68,502
| +29% | +$11.3M | 0.19% | 63 |
|
|
2024
Q1 | $42.5M | Sell |
233,489
-6,385
| -3% | -$1.1M | 0.16% | 69 |
|
|
2023
Q4 | $37.2M | Sell |
239,874
-4,049
| -2% | -$590K | 0.16% | 75 |
|
|
2023
Q3 | $36.4M | Buy |
243,923
+13,173
| +6% | +$1.93M | 0.21% | 59 |
|
|
2023
Q2 | $31.1M | Buy |
230,750
+27,121
| +13% | +$3.98M | 0.18% | 70 |
|
|
2023
Q1 | $32.5M | Buy |
203,629
+2,013
| +1% | +$308K | 0.22% | 66 |
|
|
2022
Q4 | $32.6M | Buy |
201,616
+57,947
| +40% | +$8.89M | 0.27% | 61 |
|
|
2022
Q3 | $19.3M | Buy |
143,669
+74,096
| +107% | +$10.6M | 0.21% | 83 |
|
|
2022
Q2 | $10.7M | Sell |
69,573
-20,343
| -23% | -$3.11M | 0.1% | 127 |
|
|
2022
Q1 | $14.6M | Sell |
89,916
-11,537
| -11% | -$1.68M | 0.09% | 142 |
|
|
2021
Q4 | $13.7M | Buy |
101,453
+15,900
| +19% | +$1.88M | 0.07% | 148 |
|
|
2021
Q3 | $9.23M | Buy |
85,553
+26,394
| +45% | +$3.02M | 0.06% | 171 |
|
|
2021
Q2 | $6.66M | Sell |
59,159
-5,633
| -9% | -$634K | 0.04% | 255 |
|
|
2021
Q1 | $7.01M | Buy |
64,792
+26,249
| +68% | +$2.81M | 0.05% | 223 |
|
|
2020
Q4 | $4.13M | Sell |
38,543
-15,949
| -29% | -$1.53M | 0.04% | 268 |
|
|
2020
Q3 | $4.77M | Buy |
54,492
+1,173
| +2% | +$110K | 0.06% | 187 |
|
|
2020
Q2 | $5.24M | Buy |
53,319
+34,255
| +180% | +$3.02M | 0.07% | 165 |
|
|
2020
Q1 | $1.45M | Sell |
19,064
-65,533
| -77% | -$5.58M | 0.06% | 200 |
|
|
2019
Q4 | $7.49M | Sell |
84,597
-10,004
| -11% | -$831K | 0.12% | 101 |
|
|
2019
Q3 | $7.16M | Buy |
94,601
+23,052
| +32% | +$1.58M | 0.11% | 100 |
|
|
2019
Q2 | $5.2M | Buy |
71,549
+4,815
| +7% | +$378K | 0.09% | 153 |
|
|
2019
Q1 | $5.38M | Buy |
+66,734
| New | +$5.46M | 0.09% | 124 |
|
|
2018
Q2 | – | Sell |
-32,978
| Closed | -$3.12M | – | 649 |
|
|
2018
Q1 | $3.12M | Buy |
+32,978
| New | +$3.62M | 0.05% | 199 |
|
|
2017
Q4 | – | Sell |
-46,336
| Closed | -$4.12M | – | 700 |
|
|
2017
Q3 | $4.12M | Buy |
+46,336
| New | +$3.53M | 0.09% | 115 |
|
|
2017
Q2 | – | Sell |
-7,418
| Closed | -$483K | – | 545 |
|
|
2017
Q1 | $483K | Buy |
7,418
+205
| +3% | +$12.9K | 0.01% | 486 |
|
|
2016
Q4 | $452K | Sell |
7,213
-50,229
| -87% | -$3.07M | 0.02% | 331 |
|
|
2016
Q3 | $3.62M | Buy |
57,442
+47,803
| +496% | +$3.09M | 0.13% | 55 |
|
|
2016
Q2 | $597K | Sell |
9,639
-2,638
| -21% | -$161K | 0.04% | 313 |
|
|
2016
Q1 | $701K | Sell |
12,277
-872
| -7% | -$48.6K | 0.04% | 351 |
|
|
2015
Q4 | $779K | Sell |
13,149
-2,053
| -14% | -$118K | 0.09% | 282 |
|
|
2015
Q3 | $827K | Buy |
15,202
+12,158
| +399% | +$791K | 0.07% | 265 |
|
|
2015
Q2 | $205K | Buy |
+3,044
| New | +$199K | 0.01% | 504 |
|
|
2014
Q4 | – | Sell |
-3,500
| Closed | -$202K | – | 351 |
|
|
2014
Q3 | $202K | Buy |
+3,500
| New | +$194K | 0.02% | 343 |
|
Other funds holding ABBV
VCM
VPM
Rafferty Asset Management's ABBV Position: Q1 2026 in Review
Rafferty Asset Management reduced its AbbVie (ABBV) stake by 28% in Q1 2026, selling an estimated $13.3M and leaving 156,378 shares worth $34M. The position accounts for 0.14% of the portfolio, ranked #85.
Rafferty Asset Management first reported a position in ABBV in Q3 2014 and has held it in 40 quarters since. The position peaked at $54.2M in Q3 2025. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Rafferty Asset Management held 156,378 shares of AbbVie worth $34M as of Q1 2026.
- Rafferty Asset Management sold 59,740 AbbVie shares in Q1 2026, an estimated $13.3M.
- AbbVie made up 0.14% of Rafferty Asset Management's portfolio in Q1 2026, its #85 holding.
- Rafferty Asset Management first reported a position in AbbVie in Q3 2014 and has held it in 40 quarters since.
- Rafferty Asset Management's AbbVie position peaked at $54.2M in Q3 2025.
- 4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Rafferty Asset Management's 13F filing for Q1 2026, filed 15 May 2026.